Ariadna Clos
Overview
Explore the profile of Ariadna Clos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fortuny M, Sarrias M, Torner M, Iborra I, Clos A, Ardevol A, et al.
Eur J Clin Invest
. 2023 Oct;
54(2):e14111.
PMID: 37849372
Background: Calprotectin is a calcium-binding-S100-protein synthetized mainly in neutrophils which has been demonstrated to be an accurate biomarker of the presence of these cells. Gut barrier dysfunction in patients with...
2.
Soria A, Calvo M, Casas M, Vidales Z, Munoz-Martinez S, Sapena V, et al.
Front Oncol
. 2022 Aug;
12:829483.
PMID: 35982971
Introduction: The first-line treatment for advanced hepatocellular carcinoma (HCC) is atezolizumab plus bevacizumab, but its availability is not universal and elderly patients are underrepresented in clinical trials. There is little...
3.
Masnou H, Luna D, Castillo E, Galindo M, Ardevol A, Clos A, et al.
Gastroenterol Hepatol
. 2021 Jun;
45(6):424-431.
PMID: 34118317
Background: Acute-on-chronic liver failure (ACLF) is a common syndrome that occurs in patients with advanced chronic liver disease. It consists of the rapid failure of various organs and is associated...
4.
Guasch M, Canete F, Ordas I, Iglesias-Flores E, Clos A, Gisbert J, et al.
J Gastroenterol Hepatol
. 2020 May;
35(12):2080-2087.
PMID: 32350906
Background And Aim: Biological therapies may be changing the natural history of inflammatory bowel diseases (IBDs), reducing the need for surgical intervention. We aimed to assess whether the availability of...
5.
Carrillo-Reixach J, Torrens L, Simon-Coma M, Royo L, Domingo-Sabat M, Abril-Fornaguera J, et al.
J Hepatol
. 2020 Apr;
73(2):328-341.
PMID: 32240714
Background & Aims: Hepatoblastoma (HB) is a rare disease. Nevertheless, it is the predominant pediatric liver cancer, with limited therapeutic options for patients with aggressive tumors. Herein, we aimed to...
6.
Canete F, Manosa M, Clos A, Cabre E, Domenech E
Aliment Pharmacol Ther
. 2018 Sep;
48(8):807-816.
PMID: 30178869
Background: The convoluted relationship between obesity, bariatric surgery and inflammatory bowel disease (IBD) is of increasing interest. Aim: To analyse evidence regarding the role of bariatric surgery in the development...
7.
Torres P, Lobaton T, Canete F, Clos A, Manosa M, Cabre E, et al.
Gastroenterol Hepatol
. 2017 Jul;
41(7):453-454.
PMID: 28734481
No abstract available.
8.
Clos A, Hernandez A, Sanchez M, Tenesa M, Julian J, Armengol C, et al.
Gastroenterol Hepatol
. 2016 Mar;
40(4):286-288.
PMID: 26994525
No abstract available.